X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cipla with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs ADCOCK INGRAM (S. Africa) - Comparison Results

CIPLA    Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIPLA   ADCOCK INGRAM
EQUITY SHARE DATA
    CIPLA
Mar-17
ADCOCK INGRAM
Jun-14
CIPLA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs622353-   
Low Rs458255-   
Sales per share (Unadj.) Rs181.9105.0-  
Earnings per share (Unadj.) Rs12.9-26.5-  
Cash flow per share (Unadj.) Rs29.3-21.9-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs155.782.4-  
Shares outstanding (eoy) m804.51168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.02.9 102.6%   
Avg P/E ratio x42.0-11.5 -365.5%  
P/CF ratio (eoy) x18.4-13.9 -133.0%  
Price / Book Value ratio x3.53.7 94.1%  
Dividend payout %15.50-   
Avg Mkt Cap Rs m434,51651,290 847.2%   
No. of employees `00023.04.3 536.8%   
Total wages/salary Rs m26,3383,219 818.2%   
Avg. sales/employee Rs Th6,349.14,129.2 153.8%   
Avg. wages/employee Rs Th1,143.0749.8 152.4%   
Avg. net profit/employee Rs Th449.3-1,040.5 -43.2%   
INCOME DATA
Net Sales Rs m146,30217,727 825.3%  
Other income Rs m2,287124 1,842.2%   
Total revenues Rs m148,58917,851 832.4%   
Gross profit Rs m24,758-3,072 -805.9%  
Depreciation Rs m13,229765 1,729.1%   
Interest Rs m1,594480 331.9%   
Profit before tax Rs m12,222-4,193 -291.5%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m-700-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,798262 686.1%   
Profit after tax Rs m10,354-4,467 -231.8%  
Gross profit margin %16.9-17.3 -97.7%  
Effective tax rate %14.7-6.2 -235.4%   
Net profit margin %7.1-25.2 -28.1%  
BALANCE SHEET DATA
Current assets Rs m87,37012,983 672.9%   
Current liabilities Rs m33,0817,305 452.9%   
Net working cap to sales %37.132.0 115.8%  
Current ratio x2.61.8 148.6%  
Inventory Days Days87111 78.4%  
Debtors Days Days62124 50.3%  
Net fixed assets Rs m111,5677,568 1,474.2%   
Share capital Rs m1,60982 1,955.0%   
"Free" reserves Rs m123,6450-   
Net worth Rs m125,25413,914 900.2%   
Long term debt Rs m36,4544,889 745.6%   
Total assets Rs m209,53226,284 797.2%  
Interest coverage x8.7-7.7 -112.1%   
Debt to equity ratio x0.30.4 82.8%  
Sales to assets ratio x0.70.7 103.5%   
Return on assets %5.7-15.2 -37.6%  
Return on equity %8.3-32.1 -25.7%  
Return on capital %8.5-19.8 -42.9%  
Exports to sales %34.20-   
Imports to sales %8.30-   
Net fx Rs m33,3880-   
CASH FLOW
From Operations Rs m23,8241,513 1,574.5%  
From Investments Rs m-13,127-465 2,825.3%  
From Financial Activity Rs m-13,2394,438 -298.3%  
Net Cashflow Rs m-2,4785,486 -45.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.87 Rs / ZAR

Compare CIPLA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare CIPLA With: ALEMBIC PHARMA  UNICHEM LAB  PLETHICO PHARMA  AJANTA PHARMA  DISHMAN PHARMA  



Today's Market

Sensex Trades Marginally Higher; Pharma Stocks Among Top Gainers(01:30 pm)

After opening the day in green, share markets in India witnessed choppy trades and are presently trading marginally above the dotted line.

Related Views On News

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Aug 22, 2017 03:26 PM

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS